beta-D-Galp-(1->4)-alpha-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Term ID

CHEBI:70849

Synonyms

beta-D-Gal-(1->4)-alpha-D-GlcNAc-(1->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc
beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1->6)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
beta-D-galactosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-glucosyl-(1->6)-beta-D-galactosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucose
beta-D-galactosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-(1->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine
Galb1-4GlcNAca1-6Galb1-4GlcNAcb
Galbeta1-4GlcNAcalpha1-6Galbeta1-4GlcNAcbeta

Definition

A linear amino tetrasaccharide comprised of β-D-galactose, N-acetyl-α-D-glucosamine, β-D-galactose and N-acetyl-β-D-glucosamineresidues linked sequentially (1→4), (1→6) and (1→4).

References

glygen:G46568RJ
glytoucan:G46568RJ
pubmed:19443021
pubmed:31537530

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->4)-alpha-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype where environments contain beta-D-Galp-(1->4)-alpha-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype modified by environments containing beta-D-Galp-(1->4)-alpha-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype affecting beta-D-Galp-(1->4)-alpha-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Human Disease Model